Search Within

William Pao

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (36)
  2. Meeting Abstract (30)
Groups
  1. GSK Faculty (66)
  2. Human Oncology and Pathogenesis Program (66)
  3. Tow Center for Developmental Oncology (TCDO) (65)
  4. Department of Pathology and Laboratory Medicine (64)
  5. Department of Medicine (51)
  6. Solid Tumor Oncology Division (51)

More Groups

People
  1. Marc Ladanyi (64)
  2. Mark Kris (38)
  3. Maureen Zakowski (37)
  4. Gregory Riely (33)
  5. Vincent Miller (33)
  6. Valerie Rusch (25)

More People

Years
  1. 2012 (1)
  2. 2011 (4)
  3. 2010 (7)
  4. 2009 (13)
  5. 2008 (12)
  6. 2007 (10)

More Years

Publications
  1. Clinical Cancer Research (14)
  2. Journal of Clinical Oncology (14)
  3. Journal of Thoracic Oncology (6)
  4. Journal of Molecular Diagnostics (4)
  5. Modern Pathology (4)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. American Society of Clinical Oncology (14)
  3. Nature Publishing Group (7)
  4. Elsevier Inc. (6)
  5. Elsevier Science, Inc. (4)
  6. Nature Research (4)

More Publishers

Results (66)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
    Journal Article

    Girard, N.; Sima, C. S.; Jackman, D. M.; Sequist, L. V.; Chen, H.; Yang, J. C. H.; Ji, H.; Waltman, B.; Rosell, R.; Taron, M.; more...
    European Respiratory Journal (2012)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
    Journal Article

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Sima, C. S.; Kass, S. L.; Riely, G. J.; Pao, W.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene
    Journal Article

    Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
    Journal Article

    Oxnard, G. R.; Arcila, M. E.; Sima, C. S.; Riely, G. J.; Chmielecki, J.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay
    Journal Article

    Arcila, M. E.; Oxnard, G. R.; Nafa, K.; Riely, G. J.; Solomon, S. B.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Miller, V. A.; Ladanyi, M.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)
    Meeting Abstract

    Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma
    Meeting Abstract

    Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development
    Journal Article

    Zhao, B.; Oxnard, G. R.; Moskowitz, C. S.; Kris, M. G.; Pao, W.; Guo, P.; Rusch, V.; Ladanyi, M.; Rizvi, N. A.; Schwartz, L. H.
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies
    Journal Article

    Veeriah, S.; Taylor, B. S.; Meng, S.; Fang, F.; Yilmaz, E.; Vivanco, I.; Janakiraman, M.; Schultz, N.; Hanrahan, A. J.; Pao, W.; more...
    Nature Genetics (2010)

    Fulltext@MSK | Save
  • Core needle lung biopsy specimens: Adequacy for EGFR and KRAS mutational analysis
    Journal Article

    Solomon, S. B.; Zakowski, M. F.; Pao, W.; Thornton, R. H.; Ladanyi, M.; Kris, M. G.; Rusch, V. W.; Rizvi, N. A.
    American Journal of Roentgenology (2010)

    Fulltext@MSK | Save